Brookings Report Examines Private Sector Spending On Global Health R&D, Discusses Barriers, Opportunities

Brookings Institution: How much does the private sector invest in global health R&D?
Jake Schneider, research assistant, John Villasenor, nonresident senior fellow of governance studies at the Center for Technology Innovation, and Darrell West, director and vice president of governance studies and founding director of the Center for Technology Innovation, all at the Brookings Institution, discuss results from a new Brookings report examining the private sector and global health R&D spending. “Looking to the future, private sector spending in global health R&D must increase to counteract a likely slowdown in public health investment,” the authors write. In the paper, they “make several recommendations for improving private investment in global health R&D” and “argue that there is a mismatch between investment levels and the burden of disease … for specific diseases” (9/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.